Literature DB >> 22526178

[Sacrocolpopexy - pro laparoscopic].

M Hatzinger1, M Sohn.   

Abstract

Innovative techniques have a really magical attraction for physicians as well as for patients. The number of robotic-assisted procedures worldwide has almost tripled from 80,000 procedures in the year 2007 to 205,000 procedures in 2010. In the same time the total number of Da Vinci surgery systems sold climbed from 800 to 1,400. Advantages, such as three-dimensional visualization, a tremor-filter, an excellent instrument handling with 6 degrees of freedom and better ergonomics, together with aggressive marketing led to a veritable flood of new Da Vinci acquisitions in the whole world. Many just took the opportunity to introduce a new instrument to save a long learning curve and start immediately in the surgical master class.If Da Vinci sacrocolpopexy is compared with the conventional laparoscopic approach, robotic-assisted sacrocolpopexy shows a significantly longer duration of the procedure, a higher need for postoperative analgesics, much higher costs and an identical functional outcome without any advantage over the conventional laparoscopic approach. Although the use of robotic-assisted systems shows a significantly lower learning curve for laparoscopic beginners, it only shows minimal advantages for the experienced laparoscopic surgeon. Therefore it remains uncertain whether robotic-assisted surgery shows a significant advantage compared to the conventional laparoscopic surgery, especially with small reconstructive laparoscopic procedures such as sacrocolpopexy.

Entities:  

Mesh:

Year:  2012        PMID: 22526178     DOI: 10.1007/s00120-012-2864-z

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  20 in total

1.  New technology and health care costs--the case of robot-assisted surgery.

Authors:  Gabriel I Barbash; Sherry A Glied
Journal:  N Engl J Med       Date:  2010-08-19       Impact factor: 91.245

2.  A comparison of laparoscopic and robotic assisted suturing performance by experts and novices.

Authors:  Venita Chandra; Deepika Nehra; Richard Parent; Russell Woo; Rosette Reyes; Tina Hernandez-Boussard; Sanjeev Dutta
Journal:  Surgery       Date:  2009-12-31       Impact factor: 3.982

Review 3.  Role of robotic surgery in urogynecologic surgery.

Authors:  M Louis Moy; Sharon Y Byun
Journal:  Curr Opin Urol       Date:  2010-01       Impact factor: 2.309

4.  Long-term results of robotic assisted laparoscopic sacrocolpopexy for the treatment of high grade vaginal vault prolapse.

Authors:  Daniel S Elliott; Amy E Krambeck; George K Chow
Journal:  J Urol       Date:  2006-08       Impact factor: 7.450

Review 5.  Prolapse surgery: which technique and when?

Authors:  John P F A Heesakkers; Mark E Vierhout
Journal:  Curr Opin Urol       Date:  2011-07       Impact factor: 2.309

Review 6.  Is robotic sacrocolpopexy a marketing gimmick or a technological advancement?

Authors:  Ja-Hong Kim; Jennifer T Anger
Journal:  Curr Opin Urol       Date:  2010-07       Impact factor: 2.309

7.  Long-term outcomes after robotic sacrocolpopexy in pelvic organ prolapse: prospective analysis.

Authors:  Jesús Moreno Sierra; Elena Ortiz Oshiro; Cristina Fernandez Pérez; Isabel Galante Romo; Javier Corral Rosillo; Sara Prieto Nogal; Ignacio T Castillon Vela; Angel Silmi Moyano; J Alvarez Fernandez-Represa
Journal:  Urol Int       Date:  2011-02-24       Impact factor: 2.089

8.  Laparoscopic colposuspension for total vaginal prolapse.

Authors:  A Ostrzenski
Journal:  Int J Gynaecol Obstet       Date:  1996-11       Impact factor: 3.561

9.  Laparoscopic sacral colpopexy approach for genito-urinary prolapse: experience with 363 cases.

Authors:  Francois Rozet; Eric Mandron; Carlos Arroyo; Henry Andrews; Xavier Cathelineau; Annick Mombet; Nathalie Cathala; Guy Vallancien
Journal:  Eur Urol       Date:  2005-02       Impact factor: 20.096

10.  Robotic-assisted sacrocolpopexy: technique and learning curve.

Authors:  Mohamed N Akl; Jaime B Long; Dobie L Giles; Jeffrey L Cornella; Paul D Pettit; Anita H Chen; Paul M Magtibay
Journal:  Surg Endosc       Date:  2009-01-27       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.